Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma-Reference-Cited by-同舟云学术

Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma

Published:2009-09 Issue:8 Volume:29 Page:1152-1157
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Blanchet Benoit,Hurtova Monika,Roudot-Thoraval Françoise,Costentin Charlotte E.,Barrault Camille,Jouault Hèlène,Medkour Fathia,Laurent Alexis,Duvoux Christophe,Hulin Anne

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2009.02084.x/fullpdf

Reference44 articles.

1. 1. Wiederrecht G , Lam E , Hung S , et al. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci 1993; 696: 9-19.

2. 2. Baksh S , Burakoff SJ. The role of calcineurin in lymphocyte activation. Semin Immunol 2000; 12: 405-15.

3. 3. Graef IA , Chen F , Chen L , et al. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001; 105: 863-75.

4. 4. Lambrechts D , Carmeliet P. Sculpting heart valves with NFATc and VEGF. Cell 2004; 118: 532-6.

5. 5. Schulz RA , Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004; 266: 1-16.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients;Clinical Therapeutics;2019-05

2. Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant;Gastroenterology Clinics of North America;2018-06

3. Biomarker monitoring in immunosuppressant therapy;Personalized Immunosuppression in Transplantation;2016

4. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells;Clinical Biochemistry;2015-04

5. Calcineurin Activity Assay Measurement by Liquid Chromatography–Tandem Mass Spectrometry in the Multiple Reaction Monitoring Mode;Clinical Chemistry;2014-02-01